EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Population-based, first-tier genomic newborn screening in the maternity ward

François Boemer, Kristine Hovhannesyan, Flavia Piazzon, Frédéric Minner, Myriam Mni, Valérie Jacquemin, Davood Mashhadizadeh, Noor Benmhammed, Vincent Bours, Adeline Jacquinet, Julie Harvengt, Saskia Bulk und 6 weitere

Nature Medicine · 2025-04 · 31 (4) · 1339-1350

DOI: 10.1038/s41591-024-03465-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Medicine, online erschienen am 28.01.2025. Verfasst von François Boemer und 17 weiteren Autor:innen. Beteiligte Einrichtung: Biochemical Genetics Lab, Department of Human Genetics, CHU Liege, University of Liege, Liege, Belgium. f.boemer@chuliege.be. Hauptthemen laut MEDLINE: Neonatal Screening, Genetic Testing, Genomics. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Service Public de Wallonie (Public Services Department of the Walloon Government), Sanofi, Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid development of therapies for severe and rare genetic conditions underlines the need to incorporate first-tier genetic testing into newborn screening (NBS) programs. A workflow was developed to screen newborns for 165 treatable pediatric disorders by deep sequencing of regions of interest in 405 genes. The prospective observational BabyDetect pilot project was launched in September 2022 in a maternity ward of a public hospital in the Liege area, Belgium. In this ongoing observational study, 4,260 families have been informed of the project, and 3,847 consented to participate. To date, 71 disease cases have been identified, 30 of which were not detected by conventional NBS. Glucose-6-phosphate dehydrogenase deficiency was the most frequent disorder detected, with 44 positive individuals. Of the remaining 27 cases, 17 were recessive disorders. We also identified one false-positive case in a newborn in whom two variants in the AGXT gene were identified, which were subsequently shown to be located on the maternal allele. Nine heterozygous variants were identified in genes associated with dominant conditions. Results from the BabyDetect project demonstrate the importance of integrating biochemical and genomic methods in NBS programs. Challenges must be addressed in variant interpretation within a presymptomatic population and in result reporting and diagnostic confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningGenetic TestingGenomicsHumansInfant, NewbornFemaleHigh-Throughput Nucleotide SequencingPilot ProjectsProspective StudiesBelgiumMale

Autor:innen und Institutionen

  • Biochemical Genetics Lab, Department of Human Genetics, CHU Liege, University of Liege, Liege, Belgium. f.boemer@chuliege.be.
  • Human Genetics Laboratory, GIGA-R Institute, University of Liege, Liege, Belgium.
  • Independent researcher, Liege, Belgium.
  • Division of Child Neurology, Reference Center for Neuromuscular Diseases, Department of Pediatrics, CHU Liege, University of Liege, Liege, Belgium.
  • Department of Human Genetics, CHU Liege, University of Liege, Liege, Belgium.
  • Bioinformatics Unit, Department of Human Genetics, CHU Liege, University of Liege, Liege, Belgium.

Förderung

  • Service Public de Wallonie (Public Services Department of the Walloon Government)
  • Sanofi
  • Takeda Pharmaceutical Company
  • Orchard Therapeutics Léon Frédéricq Foundation LaCAR MDx

Zitieren

APA

Boemer, F., Hovhannesyan, K., Piazzon, F., Minner, F., Mni, M., Jacquemin, V., Mashhadizadeh, D., Benmhammed, N., Bours, V., Jacquinet, A., Harvengt, J., Bulk, S., Dideberg, V., Helou, L., Palmeira, L., Dangouloff, T., BabyDetect Expert Panel, & Servais, L. (2025). Population-based, first-tier genomic newborn screening in the maternity ward. Nature Medicine, 31(4), 1339-1350. https://doi.org/10.1038/s41591-024-03465-x

Vancouver

Boemer F, Hovhannesyan K, Piazzon F, Minner F, Mni M, Jacquemin V, et al. Population-based, first-tier genomic newborn screening in the maternity ward. Nature Medicine. 2025;31(4):1339-1350. doi:10.1038/s41591-024-03465-x

BibTeX
@article{Boemer2025,
  author = {Boemer, François and Hovhannesyan, Kristine and Piazzon, Flavia and Minner, Frédéric and Mni, Myriam and Jacquemin, Valérie and Mashhadizadeh, Davood and Benmhammed, Noor and Bours, Vincent and Jacquinet, Adeline and Harvengt, Julie and Bulk, Saskia and Dideberg, Vinciane and Helou, Laura and Palmeira, Leonor and Dangouloff, Tamara and BabyDetect Expert Panel, BabyDetect Expert Panel and Servais, Laurent},
  title = {Population-based, first-tier genomic newborn screening in the maternity ward},
  journal = {Nature Medicine},
  year = {2025},
  volume = {31},
  number = {4},
  pages = {1339--1350},
  doi = {10.1038/s41591-024-03465-x}
}
Kostenlos starten →